Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

16.38
Delayed Data
As of Aug 26
 +0.16 / +0.99%
Today’s Change
11.60
Today|||52-Week Range
29.64
-15.09%
Year-to-Date
Why Raptor Pharmaceutical Corp. Is Clawing Higher Today
Aug 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close16.22
Today’s open16.22
Day’s range16.08 - 16.59
Volume349,144
Average volume (3 months)475,231
Market cap$601.7M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-97.52%
Earnings growth (next 5 years)+138.00%
Revenue growth (last year)+254.19%
P/E ratio6.5
Price/Sales7.26
Price/Book1.99

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.20+1.02%
NKNantKwest Inc+0.33+4.35%
INOInovio Pharmaceutica...+0.19+2.19%
AGENAgenus Inc+0.18+2.98%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.38
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs